Cravatex
397.95
+1.00(+0.25%)
Market Cap₹102.66 Cr
PE Ratio15.07
Company Performance:
1D+0.25%
1M+13.21%
6M+7.48%
1Y-9.68%
5Y+38.63%
View Company Insightsright
More news about Cravatex
29Apr 26
Cravatex Limited Completes Postal Ballot Notice Dispatch for Executive Director Re-appointment
Cravatex Limited completed dispatch of postal ballot notice through electronic mode for re-appointment of Mr. Divakar G. Kamath as Executive Director and CFO for 3 years from 1st April 2026 to 31st March 2029. E-voting through NSDL platform runs from 29th April 2026 to 28th May 2026, with cut-off date of 24th April 2026 for voting eligibility. Company published newspaper notices in Business Standard and Sakal on 29th April 2026 informing members about dispatch completion and voting procedures.
 no imag found
10Apr 26
Cravatex Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026
Cravatex Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, through registrar MUFG Intime India Private Limited. The certificate confirms proper handling of securities dematerialization processes and adherence to prescribed timelines for regulatory compliance.
 no imag found
30Mar 26
Cravatex Limited Re-appoints Divakar G. Kamath as Executive Director and CFO for Three Years
Cravatex Limited's Board of Directors re-appointed Mr. Divakar G. Kamath as Executive Director and CFO for 3 years from April 1, 2026 to March 31, 2029, subject to shareholder approval. The decision was made during a board meeting on March 30, 2026, based on the Nomination and Remuneration Committee's recommendation. Mr. Kamath, with over 32 years of banking experience, has been serving as the company's CFO since 2012.
 no imag found
12Feb 26
Cravatex Limited Reports Strong Q3FY26 Results with 7.76% Growth in Net Profit
Cravatex Limited reported strong Q3FY26 financial results with standalone net profit growing 7.76% to ₹264.02 lacs and revenue from operations increasing 23.40% to ₹313.12 lacs compared to Q3FY25. On a consolidated basis, the company achieved revenue of ₹3,678.92 lacs with net profit surging 438.33% to ₹134.76 lacs. The results were approved by the Board of Directors on February 12, 2026, and demonstrate the company's robust operational performance across both standalone and consolidated metrics.
 no imag found
12Aug 25
Cravatex Limited Reports Mixed Q1 Results: Standalone Profit Amidst Consolidated Loss
Cravatex Limited announced its Q1 financial results, showing a mixed performance. Standalone operations were profitable with revenue of Rs. 144.14 lakhs and a profit of Rs. 44.21 lakhs. However, consolidated results showed a loss of Rs. 136.77 lakhs on revenue of Rs. 2,312.69 lakhs. The company's subsidiaries, BB (UK) Limited and BB Euro GmbH, contributed Rs. 2,554.16 lakhs in total income but reported a combined net loss of Rs. 180.99 lakhs. The standalone EPS was Rs. 1.71, while the consolidated EPS was negative at Rs. 5.29.
 no imag found
Cravatex
397.95
+1.00
(+0.25%)
1 Year Returns:-9.68%
Industry Peers
Redington
276.75
(+0.64%)
MMTC
66.26
(-1.31%)
MSTC
726.85
(+1.56%)
Ravindra Energy
177.20
(+5.68%)
BN Agrochem
293.00
(+1.16%)
TCC Concept
343.80
(+3.65%)
Creative Newtech
784.60
(+2.62%)
RRP Defense
693.20
(-1.00%)